532P Integrated clinical and genomic assessment of first-line CDK4/6 inhibitor outcomes in HR+/HER2— metastatic breast cancer in real world data (RWD)
D. Lluís Garulo, M.J. Gil, Catalina Falo, A. Stradella et autres
0 citationsAnnals of Oncology
S. Recalde Penabad
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
1Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Breast Cancer Treatment StudiesInflammatory mediators and NSAID effectsBRCA gene mutations in cancerBone health and treatmentsAdvanced Breast Cancer Therapies
Publications récentes
428P Key landmarks of male advanced breast cancer: Results of the GEICAM/2016-04 study
N. Martínez, María Purificación Martínez del Prado, C. Hernando Melia, S. Recalde Penabad et autres
0 citationsAnnals of Oncology
240P Effect of dose intensity (DI) of palbociclib (PAB) and initial body weight dosage (BWD) on progression free survival (PFS): A real-world data analysis in patients with hormone-receptor (HR) positive HER2 negative metastatic breast cancer (MBC)
S. Recalde Penabad, Eduard Fort Casamartina, Silvina Otero, Cecilia Lezcano et autres
0 citationsESMO Open
Abstract P2-08-10: First results of the randomized window of opportunity clinical trial D-Biomark: Immunomodulatory effect of denosumab in early breast cancer
Andrea Vethencourt, Eva M. Trinidad, Anna Petit, María Teresa Soler-Monsó et autres
0 citationsCancer Research
14P Immunomodulatory effect of denosumab in early breast cancer: Preliminary results of a randomized window-opportunity clinical trial D-Biomark
Andrea Vethencourt, Eva M. Trinidad, Audrey Petit, T Soler et autres
1 citationAnnals of Oncology
Abstract P2-20-08: Validation and comparison of breast graded prognostic assessment score and modified breast graded prognostic assessment in patients with brain metastases as prognostic tool
Carles Fabregat Franco, Agostina Stradella, Valentín Navarro, Jenniffer Linares et autres
0 citationsCancer Research
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.